Abstract: The current work investigates tumor growth control under antiangiogenic targeted molecular therapy by use of Tensor Product (TP) transformation. During the dynamics of the tumor growth we have considered that the tumor volume x 1 (t) is measurable, while due to the lack of information about the second state x 2 (t) (the inhibitor level in the serum), we have developed an appropriate Extended Kalman Filter (EKF) to estimate it. We applied different quasi Linear Parameter Varying (qLPV) models during the design of the EKF and the controller. Tensor Product model transformation method completed with Linear Matrix Inequality based optimization have been applied to design the main controller. The reference signals were generated by trajectory tracking kind control based on Inverse Dynamic Control -Proportional Derivate compensator, applied it on the "simulated" (original) model. We did not consider any state disturbance. However, we have taken into account sensor noise in accordance with the properties of the model. We have found that all of the control goals have been satisfied with the developed control framework: (i) the tumor volume was lower than 1 mm 3 at the end of the therapy; (ii) the developed models have approached each other with good accuracy; (iii) the totally injected inhibitor level was physiologically acceptable.
Introduction
Targeted Molecular Therapies (TMTs) are advanced tumor therapeutic possibilities which can be used beside the classical treatments (e.g. chemotherapy, radiotherapy, etc.). TMT drugs directly inhibit the specific biochemical pathways used by the different kinds of cancers in order for growing, proliferation and spreading [1, 2] . Hence, by TMTs more personalized treatment can be achieved focusing on the vital phenomena of the tumor and applying specific drugs [3] . The main benefits of TMTs are less damaging to the normal cells, causing less side effects, improving the efficiency of regular therapies and improving the quality of life of the patients [2] . Among the several types of TMTs the mostly commonly used ones are the apoptosis inducers, gene expression inhibitors, signal transmission inhibitors and anti-angiogenic therapies [3] .
Angiogen inhibitors are commonly used in modern medicine by targeting the socalled pro-angiogen factor, the vascular endothelial growth factor (VEGF) that indicates the endothelial proliferation leading to the formation of new blood vessels. The tumors produce VEGF in order to get new blood vessels through which they are able to get the nutrients for further growing. By inhibiting this molecular pathway, the new blood vessels formation phenomena can be decreased causing the "starvation" of the tumor [3] [4] [5] . The nature of this process is an excellent therapeutic target to be combined with control engineering methodologies optimizing the drug injection and therapy outcomes [6] . One of the most commonly used TMT drugs in case of angiogen inhibition is bevacizumab which is investigated in this study as well as the parametric identification done by the preparation of the applied model [7] .
Similarly to other physiological control applications like diabetes or anesthesia [8] [9] [10] [11] [12] [13] the control of tumor growth is challenging due to several unfavorable effects that should be taken into account. The nonlinear nature of the process completed with cross-effects, parameter and model uncertainties and time-delays increases the difficulty of the problem. Recently, several results appeared in the topic of antiangiogenic TMT control problem [6, [14] [15] [16] [17] [18] .
The current work investigates the combined applicability of advanced control methodologies. One of the most promising ones is represented by the LPV framework, a useful technique to apply the well-developed linear control methods on the original nonlinear model without linearizing it [19] . The TP model transformation represents another solution that can be combined with LMI based optimization and can be done on LPV functions as well, making it possible to design TP-LPV-LMI kind controllers [20] . These kind of controllers have many beneficial properties: the parameter uncertainties and the nonlinearities can be embedded into the model making the designed controller robust against these effects. Furthermore, the control requirements can be formulated as LMIs, which can be taken into account during the design procedure in order to guarantee their satisfaction by the control action.
On the other hand, not all of the state variables of given models are available. One suitable solution to deal with this problem is definitely Kalman-filtering. The Extended Kalman Filter (EKF) represents an estimator designed for nonlinear systems that can be used effectively for highly nonlinear as well [21] .
The paper is structured as follows: first, the minimal tumor growth model and the developed qLPV models are introduced. After, the controller design procedure is detailed including the TP model transformation, the LMI based optimization, the EKF design and the development of the reference subsystem. Finally, the results of the numerical simulations are presented, done in MATLAB environment.
Tumor Growth Models

The Examined Tumor Growth Model
The current study focuses on the minimal tumor growth model [22, 23] . This secondorder model includes two state variables: x 1 (t) [mm 3 ] for the tumor volume and x 2 (t) [mg/kg] as the serum inhibitor level:
The control input is represented by the inhibitor intake u(t) [mg/kg/day], while the output of the model is the x 1 (t) tumor volume -that is assumed to be measurable. . These values are coming from parametric identification done on measurements from mice experiments related to C38 colon adenocarcinoma [22] .
As a result, the model is a simple mathematical formulation of the phenomena. It is assumed that by using only antiangiogen inhibitor (e.g. bevacizumab [24] ) the tumor volume can be maintained and decreased. In the lack of inhibitor, the x 1 (t) tumor volume grows limitlessly with the dynamics determined by a. The nontrivial equilibrium of the model can be calculated as follows:
from which x 1,∞ and u ∞ becomes:
Hence, x 2,∞ and u ∞ are independent from x 1,∞ . It is easy to see that x 2 (t) = a/b is needed to keep the tumor volume on a certain level and x 2 (t) > a/b should be used to decrease the x 1 (t). The belonging control signals are u(t) = c·a/b and u(t) > c·a/b, respectively. These requirements have to be taken into account during the controller design.
It should be noted that a lower limit was applied against the tumor volume in all kind of models appearing in this study: min(x 1 (t)) = min(x 1,re f (t)) = min(x 1 (t)) = 10 −3 mm 3 -which is an approximation of the zero level. From the antiangiogenic TMTs point of view this is reasonable since the goal of these kinds of therapies are usually not to eliminate (kill) the tumor itself, but to keep its volume under a certain level [25] .
The Reference Model
As it will be introduced later, the main goal of the control is to enforce the original nonlinear model to behave as a given -beneficiary selected -reference model. As x 1 (t) can be measured, a simple model was developed with decreasing state trajectory:
where ξ is a scalar and t represents the time. x re f (t 0 ) is the -known -initial value of the reference model which can be determined by exact measurement (if
). This reference model will be used for trajectory determination during the controller design.
qLPV Model Development
In conformity with [26] [27] [28] , the general state-space form of an LPV model is the following:
The considered vectors and parameter dependent matrices are:
) ∈ R k×m feedforward matrix and S(p(t)) ∈ R (n+k)×(n+m) system matrix -the latter one is the so-called LPV function (inasmuch any of the state variables is involved as scheduling variable we call it quasi-LPV (qLPV) model and qLPV function [27] ). The matrices in (5) are dependent from the p(t) ∈ Ω R ∈ R R parameter vector that consists of the so-called scheduling variables p i (t), namely,
hypercube -a subspace of the R R real vector space -is characterized by the extremes of the p i (t).
As it will be seen in the subsequent sections, two different qLPV models have been developed and applied. In order to avoid any misunderstanding, alternative notations for the parameter vectors belonging to the qLPV model were used. In case of Model-I q(t) = q(t) ∈ R 1 , while for Model-II this is p(t) ∈ R 2 .
Model-I
We have selected the q(t) = x 1 (t) as scheduling variable from (1) which leads to the following qLPV model:
where the I subscript is related to Model-I. In this case, B I = B and C I = C are equal to each other due to the lack of specific transformation -we only pointed out one state variable. The selected range for q(t)is{10 −3 , . . . , 5 × 10 5 }. The lower boundary is related to the aforementioned limitation against the tumor volume. The upper boundary is in conformity with our previous investigations [6] . Model-I was developed to support the EKF design and application as it will be introduced later.
Model-II
In order to apply state feedback kind controller without reference compensation, a corresponding qLPV model is necessary. The difference based control oriented qLPV models can be a solution for this issue [29] . In this case, the deviation between the states of the model to be controlled and from the states of a given reference system should be modeled, namely, the dynamics of the "state error". For the actual problem this means: ∆x 1 (t) = x 1 (t)−x 1,re f (t), ∆x 2 (t) = x 2 (t)−x 2,re f (t) and ∆u(t) = u(t)−u re f (t). By this transformation the control goal is transformed as well: instead of reaching a certain value by the state variables the new control goal becomes -reaching zero level by the states over time. Hence,
In case of a state feedback kind controller this can be obtained, if we use the ∆r = 0 2×1 reference signal and the ∆x(t) is compared to this zero reference. The derivation of the transformed differential equations is the following:
The state-space form of (7) will be the following:
The selected scheduling variables have been p 1 (t) = x 2,re f (t) ∈ {a/b+10 −3 , . . . , 10 4 } and
. If the goal is to keep the tumor's level on a certain value, x 2 = a/b should be reached via u = c · a/b. Consequently, we have approached the a/b by a/b + 10 −3 in order to increase the numerical stability, further, to keep the controllability of Model-II. p 1,max = 10 4 is considered the maximum value which may occur [6] , while p 2,min and p 2,max are the same as in case of q discussed in Model-I.
3 Control Design
TP Model Transformation and Control
By TP model transformation it was possible to convert the qLPV function into convex polytopic TP model form. The resulting TP model is able to describe the initial qLPV function and through the original nonlinear system with given accuracy. The usability of this tool has been proven several times for highly nonlinear systems (e.g. [20, [30] [31] [32] [33] ), what the physiological systems are in general [34] . Applying the TP model transformation on the qLPV function of (5), the following finite element convex polytopic TP model is obtained:
The core tensor S ∈ R I 1 ×I 2 ×...×I R ×(n+k)×(n+m) consists of the S i 1 ,i 2 ,...,i R LTI vertices. The w r (p r (t)) weighting vector function consists of the w r,i r (p r (t)) (i r = 1...I R ) continuous convex weighting functions. The convexity is held, if ∀r, i, p r (t) :
w r,i r (p r (t)) ∈ [0, 1] and ∀r, p r (t) :
Different kinds of convex hulls can be applied during the TP model transformation.
In this study the Minimal Volume Simplex (MVS) convex hull was considered that allows the use of the smallest convex hull inside Ω [35] . However, the TP model approximating the original model inside the Ω hypercube with certain accuracy depends on the applied sampling resolution in Ω [36] . The practical realization of the TP model transformation can be found in [20, 31, 36, 37] .
In case of general state-feedback control, the control signal can be generated in the LPV case as follows [20, 27, 30, 31] :
if the case is r(t) = 0 n×1 -which is in conformity with (8) and the used Model-II. In (10), the G(p(t)) ∈ R m×n is the parameter dependent controller gain. Consequently, the polytopic convex TP controller becomes:
As a result, the G feedback tensor consisting by G i 1 ,i 2 ,...,i R feedback gain matrices belongs to the given S i 1 ,i 2 ,...,i R LTI systems. The w r (p r (t)) convex weighting functions are the same as in (7). Further derivations, explanations and case studies can be found in [32, 35, 36, 38] . The TP model transformation has been successfully adopted and applied in many technical fields thanks to the continuous improvements in the recent times. New approaches have appeared regarding the computational improvements related to TP model transformation [39, 40] . The latest research explored that the LMI based controller design methods are sensitive to the applied convex hulls. Hence, the selection of the applicable convex hull manipulation and the convex hull candidate with respect to the LMI based controller design methods is a critical aspect [31, [41] [42] [43] . Effective convex hull manipulation techniques are introduced in [35, 44, 45] . The application of the TP model based control can be found both in physical control systems [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] and it was applied in case of physiological controls as well [60] [61] [62] [63] [64] [65] [66] . Many other important control approaches regarding the TP model transformation have been elaborated in [56, [67] [68] [69] [70] [71] [72] [73] [74] 
Linear Matrix Inequality based Optimization
In accordance with Lyapunov's direct method, anẋ(t) = Ax(t) system is stable if there exists a V (x) = x Px positive definite quadratic Lyapunov function and theV (x) = x (A P + PA)x is negative definite, namely, A P + PA < 0 and P = P > 0 [20, 75] . [20] . By utilizing the V (x(t)) = x Px = x X −1 x Lyapunov function, the controller candidate becomes [36] :
By realizing the derivative of the Lyapunov function, the following term appears, where "Sym" acronym means symmetric:
The symmetric term can be described by using the polytopic weighting functions as follows:
The S(p(t)) = Co(S 1 , S 2 , . . . , S R ) and G(p(t)) = Co (G 1 , G 2 , . . . , G R ) are polytopic structures -the "Co" acronym means convex combination. In this study, we have applied Parallel Distributed Compensation (PDC) type control. This is possible if the same w(p(t)) weighting functions are used (to describe the polytopic qLPV system and the controller) citeBaranyi:2013. As a result, LMI optimization can be used in order to design a quadratically stabilizing PDC for continuous polytopic systems [75] :
where X n×n is a positive definite and symmetric matrix, M m×n i is the supplementary matrix and w i and w j are general polytopic weighting functions, respectively.
In accordance with [36, 75] , the control gain is calculated as follows:
As the level of injectable inhibitor level is limited -in conjunction with the physiological reality -an LMI constraint was applied on the control input to avoid the unrealistically high injections from the drug.
By using (16), the u(t) 2 ≤ µ at t ≥ 0 can be guaranteed. This is true if x(0) lies in the polytope, which needs that x(t 0 ) 2 ≤ 1, as it is stated in [76] . We have considered the Model-II from (8) during the controller design via LMI optimization. Due to the constraint on p 1,min , the rank(C (A II (p(t)), B II )) = n = 2 ∀ p(t), namely, the controllability property of Model-II can be kept in the Ω parameter domain.
Extended Kalman Filter Design
The use of mixed continuous/discrete EKF is quite common regard to physiological applications, as the process to be estimated is continuous, however, the measurements are performed by discrete sensors [21, 77, 78] . During the EKF design we have applied the Model-I qLPV model. The assumed sampling time was considered T = 1 day in accordance with the model properties of (1).
Hence, the general system description regard to the EKF becomes [21] :
where f = A I (p(t))x(t) + B I u(t) is the system equation from (6) and x k = x(t k ). The w(t) represents the continuous disturbance, while v k is the discrete noise signal. The h is the discrete sensor model and is equal to h = C I x k from (6) since the discretization does not modify the output model in this case.
Due to the properties of the original model no system disturbance was considered.
From the design point of view that means Q(t) = 0 n×n . However, we assumed moderate measurement noise: R k = σ 2 = 50 2 . The applied σ variance was arbitrarily selected -to be reasonable compared to the magnitude of the output.
The considered initial conditions have considered the followings:x 0|0 = E x(t 0 ) and P 0|0 = Var x(t 0 ) . The prediction phase of the mixed EKF is to solve the following differential equations with respect to Model-I:
. The obtained results are applied in the updating phase of the EKF as follows:x k|k−1 =x(t k ) and
Consequently, the so-called Kalman gain is calculated as the first part of the updating phase:
here, the
. Finally, the last step of the EKF design and operation is the correction of the prediction with respect to the measurement by using the calculated Kalman gain:
at which I is an identity matrix.
Design of the Reference Trajectories
In order to design the u re f (t) and the reference state trajectories x re f (t), the socalled inverse dynamics compensation was applied (a widely used tool in robotics), and completed with proportional-derivative (IDC-PD) compensator [8, 79, 80] .
In case of the IDC-PD compensator the first step is to determine the direct connection between the control signal and the controlled variable in order to map the control effect via the model; moreover, to determine the order of the control. In the current case, the u(t) directly affects theẍ 1 (t) according to (1) . Thus, it is possible to define a suitable description forẍ 1 (t) -in our case (4) has applied. The next step is to elaborate the second derivative of (4):
As a result, the general second order compensator can be written [80] :
where F is the weighting parameter of the second derivative of the error function, F D is the derivative weighting parameter of the first derivative of the error function, F P is the proportional weighting parameter of the the error function, z nom (t) is the desired nominal state trajectory and z(t) is the state variable to be controlled.
As the idea is to characterize the reference system, (1) is used to describe it:
Here the original system is considered as an exactly known and valid one. Naturally, different reference systems can be used that are able to describe the connection between the control signal and the variable to be controlled.
As the trajectory tracking is needed for x 1,re f (t), the next step is to elaborate (22) for the current problem:
It is assumed that F = 1, which is a generally used consideration in the literature [79, 80] :
We have considered a constraint for (22) taken from the assumption on p 1,min and the limitation of the model described in (1) as detailed above (decreasing the tumor volume, and keeping the controllability and numerical stability).
To sum up, by using u re f (t) from (26) as the input of (23), the x 1,re f (t) has similar behavior than x 1,nom (t) from (21) -which leads to a smooth reference trajectory to be followed by the volume of the tumor as it is enforced by the TP-LPV-LMI controller via the control framework.
Final Control Structure
The final control structure is built up from two systems as it can be seen on Figure  1 . The reference subsystem is responsible to generate the reference trajectories to be followed by the states of the original system via the control framework. It has to be pointed out that the u re f (t) design method and the reference model applied in the reference subsystem can be arbitrarily selected. The main limitation is that the u re f (t) realization should consider the constraints against the reference control signal described above and the applied reference model has to provide a close-toaccurate description about the connection between u re f (t) and x re f (t). The control framework enforces that x(t) = x re f (t), t → ∞. This is the same as ∆r = x − x re f = 0. Due to the fact that x 2 (t) cannot be measured, it is provided by the EKF during the operation andx 2 (t) is used for the difference generation.
Results of the Numerical Simulation
The realization of the control framework was done in the MATLAB framework using the forward method of Euler: dx(t 0 )/dt ≈ (x(t 0 + T ) − x(t 0 ))/T , where T represents the sampling time.
In accordance with the model properties we did not consider state disturbance neither at the EKF design nor at simulations. Therefore, we assumed that d ≡ 0. However, we assumed the presence of limited measurement noise with normal distribution: v(t) ∼ N (0, 50 2 ) mm 3 . We have taken into account this specificity during the EKF design and prepared the control framework for this action -moreover, the measurement noise only prevailed inx 1 (t). By using the EKF, the noise appeared in the u(t) -however, in an oppressed way.
A summary of the applied circumstances can be seen in Table 2 . Since x 1 (t) have been considered as measurable, we assumed that x 1 (t 0 ) is available. On the other hand, x 2 (t 0 ) = 0 represents that there is no inhibitor in the serum before the beginning of the therapy. The initial state variables of the EKF were selected by considering the previously mentioned facts: x 1 (t) is known and x 2 (t 0 ) is zero. We have appliedx 1 (t 0 ) = 30100 mm 3 taking into account that there is a measurement noise from the beginning of the simulation. However, we have applied x 2,re f (t 0 ) = a/b + 10 −3 coming from the aforementioned fact in regards to p 1,min . Figure 2 . presents the variation of the state variables x(t) belonging to the original system (upper part), while the middle and lower sub-figures represent the output y(t). The x(t) varies in accordance with the control law. At the beginning, the controller rapidly intervenes into the process and decreases the x 1 (t) under a certain level and later it enforces the system to approach the trajectories of the reference system. The middle figure shows the output y(t) from day 0 to day 60. It demonstrates that the magnitude of the output is too high compared to the v(t) and the measurement noise cannot be recognized on the signal. On the other hand, the lower figure presents the output from day 60 to day 200 (end of the therapy). The effect of the noise is clearly visible in this case due to the comparable magnitudes of y(t) and v(t). The EKF approached the original model with high precision (Figure 3 ). The aim of the control, namely, x 1 (t f inal ) < 1 mm 3 has been satisfied since, x 1 (t f inal ) = 0.2949 mm 3 . Figure 4 . shows the discrepancies between the states of the models. The initial state error between the original model and the EKF is x(t 0 ) −x(t 0 ) = [−100, 0] . As we mentioned, the measurement noise only reflects in the first state -in the outputof the EKF. The error rate can be measured by applying the two norm metric on the distance: X 1 −X 1 2 = 353.4982 mm 3 
The obtained state error is small compared to occurred magnitudes of the tumor volumes. The EKF behaves as an optimal estimator from the second state point's of view since system disturbances has not been taken into consideration and sensor noise only reflects in the first state:
Both the original model and the EKF have approached the states of the reference model with acceptable error rate within acceptable time horizon of the therapy. More precisely, the difference between x 1 (t),x 1 (t) and x 1,re f (t) was inside a range of 100 mm 3 after day 77 and continuously decreased until day 200. The deviation between x 2 (t),x 2 (t) and x 2,re f (t) was inside a range of 1 mg/kg after day 33 and continuously decreased until day 200.
Due to the small state error between the original and EKF states, the x re f (t) − x(t) characterizes the x re f (t) − x(t) as well. Therefore, we only presented here the x re f (t) −x(t). It is clearly visible thatx(t) appropriately approaches x re f (t) over time. The state errors converge to zero, although the x re f (t f inal ) −x(t f inal ) = [−18.6403, −0.0096] due to the applied disturbance. The comparison of the control signals can be seen in Figure 5 . The upper subfigure belongs to the u re f (t) and it presents that the reference control signal varies accordingly based on the above defined constraints. What can be pointed out is the flat region from 2 -5 days that is the consequence of the constraint on x 2,re f (t) coming from the already described model property: if we want to decrease the tumor volume, we need that x 2,re f (t) > a/b which requires that u re f (t) > c · a/b.
There is the higher peak in u(t) at the beginning which decreases to zero. This immediate action is a consequence of the applied state-feedback kind control due to the initial state discrepancy between x 2,re f (t 0 ) andx 2 (t 0 ). The u re f (t) − u(t) < 0.4 mg/kg/h, t > 20. Small oscillations can be seen in u(t) due to the effect of the EKF. 
Conclusions
The study details our latest achievements in regards to the control of tumor growth through antiangiogen therapy. Two qLPV models have been developed based on the original nonlinear model. The Model-I has been applied during the EKF design and operation. The Model-II was used in order to design the difference based TP-LPV-LMI controller. A reference model has been also developed to describe the behavior of the first state -this was used during the reference trajectory generation.
The controller design was a complex procedure. First, we have applied TP model transformation on the Model-II. After, the control goals have been formalized by using LMIs. The procedure resulted the convex weighting functions and the controller vertices which built up the TP-LPV-LMI controller. We have developed a reference subsystem, as well based on IDC-PD kind compensator with the purpose of generation of the reference state variables and reference control input.
The developed control framework was tested on numerical simulations scenarios. We have found that the system performed well and all of the control goals have been satisfied. Not just the tumor volume was decreased under a certain level, but the original nonlinear model was enforced to behave as the reference model as well.
In the future we plan to analyze the performance of the developed solutions in case of state disturbances. Moreover, we will investigate other reference signal possibilities as well. 
